Skip to main content

Signaling and cellular heterogeneity in cancer - Rune Toftgård, Leander Blaas, Marco Gerling

Cancer is a complex disease.
Our group tackles tumor complexity from different angles, focusing on signaling pathways (Rune Toftgård), cellular heterogeneity (Leander Blaas) and cellular interactions (Marco Gerling) in cancer development and progression.

Marco Gerling
Marco Gerling